 | • レポートコード：QYR2104Z4478 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、157ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、PCRベース腸疾患検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アナライザー/機器、キット/パネル）、用途別市場規模（クロストリジウム・ディフィシル、カンピロバクター症、コレラ、腸管出血性大腸菌感染症、ヘリコバクター・ピロリ感染症、サルモネラ症、シゲロシス、ロタウイルス感染症、ノロウイルス感染症、寄生性腸疾患）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・PCRベース腸疾患検査の市場動向 ・企業の競争状況、市場シェア ・PCRベース腸疾患検査の種類別市場規模（アナライザー/機器、キット/パネル） ・PCRベース腸疾患検査の用途別市場規模（クロストリジウム・ディフィシル、カンピロバクター症、コレラ、腸管出血性大腸菌感染症、ヘリコバクター・ピロリ感染症、サルモネラ症、シゲロシス、ロタウイルス感染症、ノロウイルス感染症、寄生性腸疾患） ・PCRベース腸疾患検査の北米市場規模2016-2027（アメリカ、カナダ） ・PCRベース腸疾患検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・PCRベース腸疾患検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・PCRベース腸疾患検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・PCRベース腸疾患検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Vela Diagnostics、CorisBioconcept、Meridian Life Science、Bio-Rad Laboratories、Abbott (ALERE)、bioMerieux SA、Trinity Biotech、DiaSorin Molecular、Etta Healthcare (Ovagene Oncology)、ExcitePCR (PositiveID Corporation)、Flow Alliance、Fluid-Screen、FluimediX、Fluxergy、Focus Diagnostics (DiaSorin Molecular)、Future Horizon Scientific、Genalyte、GeneFluidics、GenSpeed Biotech、Gulf Bio Analytical、Hahn-Schickard、Helvoet、HemoCue、Danaher、IDEX Health&Science、iLine Microsystems、Inflammatix） ・結論 |
Market Analysis and Insights: Global PCR-based Enteric Disease Testing Market
The global PCR-based Enteric Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PCR-based Enteric Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PCR-based Enteric Disease Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PCR-based Enteric Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PCR-based Enteric Disease Testing market.
Global PCR-based Enteric Disease Testing Scope and Market Size
PCR-based Enteric Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PCR-based Enteric Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Analyzers/Instruments
Kits/Panels
Segment by Application
Clostridium Difficile
Campylobacteriosis
Cholera
E. coli Infection
H. pylori Infection
Salmonellosis
Shigellosis
Rotavirus Infection
Norovirus Infection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Vela Diagnostics
CorisBioconcept
Meridian Life Science
Bio-Rad Laboratories
Abbott (ALERE)
bioMerieux SA
Trinity Biotech
DiaSorin Molecular
Etta Healthcare (Ovagene Oncology)
ExcitePCR (PositiveID Corporation)
Flow Alliance
Fluid-Screen
FluimediX
Fluxergy
Focus Diagnostics (DiaSorin Molecular)
Future Horizon Scientific
Genalyte
GeneFluidics
GenSpeed Biotech
Gulf Bio Analytical
Hahn-Schickard
Helvoet
HemoCue
Danaher
IDEX Health&Science
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analyzers/Instruments
1.2.3 Kits/Panels
1.3 Market by Application
1.3.1 Global PCR-based Enteric Disease Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clostridium Difficile
1.3.3 Campylobacteriosis
1.3.4 Cholera
1.3.5 E. coli Infection
1.3.6 H. pylori Infection
1.3.7 Salmonellosis
1.3.8 Shigellosis
1.3.9 Rotavirus Infection
1.3.10 Norovirus Infection
1.3.11 Parasitic Enteric Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PCR-based Enteric Disease Testing Market Perspective (2016-2027)
2.2 PCR-based Enteric Disease Testing Growth Trends by Regions
2.2.1 PCR-based Enteric Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 PCR-based Enteric Disease Testing Historic Market Share by Regions (2016-2021)
2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2022-2027)
2.3 PCR-based Enteric Disease Testing Industry Dynamic
2.3.1 PCR-based Enteric Disease Testing Market Trends
2.3.2 PCR-based Enteric Disease Testing Market Drivers
2.3.3 PCR-based Enteric Disease Testing Market Challenges
2.3.4 PCR-based Enteric Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR-based Enteric Disease Testing Players by Revenue
3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2016-2021)
3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2016-2021)
3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue
3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio
3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2020
3.5 PCR-based Enteric Disease Testing Key Players Head office and Area Served
3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service
3.7 Date of Enter into PCR-based Enteric Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR-based Enteric Disease Testing Breakdown Data by Type
4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2016-2021)
4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2022-2027)
5 PCR-based Enteric Disease Testing Breakdown Data by Application
5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2016-2021)
5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America PCR-based Enteric Disease Testing Market Size (2016-2027)
6.2 North America PCR-based Enteric Disease Testing Market Size by Type
6.2.1 North America PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
6.2.2 North America PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
6.2.3 North America PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
6.3 North America PCR-based Enteric Disease Testing Market Size by Application
6.3.1 North America PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
6.3.2 North America PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
6.3.3 North America PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
6.4 North America PCR-based Enteric Disease Testing Market Size by Country
6.4.1 North America PCR-based Enteric Disease Testing Market Size by Country (2016-2021)
6.4.2 North America PCR-based Enteric Disease Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe PCR-based Enteric Disease Testing Market Size (2016-2027)
7.2 Europe PCR-based Enteric Disease Testing Market Size by Type
7.2.1 Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
7.2.2 Europe PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
7.2.3 Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
7.3 Europe PCR-based Enteric Disease Testing Market Size by Application
7.3.1 Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
7.3.2 Europe PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
7.3.3 Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
7.4 Europe PCR-based Enteric Disease Testing Market Size by Country
7.4.1 Europe PCR-based Enteric Disease Testing Market Size by Country (2016-2021)
7.4.2 Europe PCR-based Enteric Disease Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size (2016-2027)
8.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type
8.2.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application
8.3.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region
8.4.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America PCR-based Enteric Disease Testing Market Size (2016-2027)
9.2 Latin America PCR-based Enteric Disease Testing Market Size by Type
9.2.1 Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
9.2.2 Latin America PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
9.2.3 Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
9.3 Latin America PCR-based Enteric Disease Testing Market Size by Application
9.3.1 Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
9.3.2 Latin America PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
9.3.3 Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
9.4 Latin America PCR-based Enteric Disease Testing Market Size by Country
9.4.1 Latin America PCR-based Enteric Disease Testing Market Size by Country (2016-2021)
9.4.2 Latin America PCR-based Enteric Disease Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size (2016-2027)
10.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type
10.2.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application
10.3.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country
10.4.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Vela Diagnostics
11.2.1 Vela Diagnostics Company Details
11.2.2 Vela Diagnostics Business Overview
11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction
11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.2.5 Vela Diagnostics Recent Development
11.3 CorisBioconcept
11.3.1 CorisBioconcept Company Details
11.3.2 CorisBioconcept Business Overview
11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction
11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.3.5 CorisBioconcept Recent Development
11.4 Meridian Life Science
11.4.1 Meridian Life Science Company Details
11.4.2 Meridian Life Science Business Overview
11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction
11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.4.5 Meridian Life Science Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction
11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Abbott (ALERE)
11.6.1 Abbott (ALERE) Company Details
11.6.2 Abbott (ALERE) Business Overview
11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction
11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.6.5 Abbott (ALERE) Recent Development
11.7 bioMerieux SA
11.7.1 bioMerieux SA Company Details
11.7.2 bioMerieux SA Business Overview
11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction
11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.7.5 bioMerieux SA Recent Development
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Details
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction
11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.8.5 Trinity Biotech Recent Development
11.9 DiaSorin Molecular
11.9.1 DiaSorin Molecular Company Details
11.9.2 DiaSorin Molecular Business Overview
11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction
11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.9.5 DiaSorin Molecular Recent Development
11.10 Etta Healthcare (Ovagene Oncology)
11.10.1 Etta Healthcare (Ovagene Oncology) Company Details
11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview
11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction
11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.10.5 Etta Healthcare (Ovagene Oncology) Recent Development
11.11 ExcitePCR (PositiveID Corporation)
11.11.1 ExcitePCR (PositiveID Corporation) Company Details
11.11.2 ExcitePCR (PositiveID Corporation) Business Overview
11.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction
11.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.11.5 ExcitePCR (PositiveID Corporation) Recent Development
11.12 Flow Alliance
11.12.1 Flow Alliance Company Details
11.12.2 Flow Alliance Business Overview
11.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction
11.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.12.5 Flow Alliance Recent Development
11.13 Fluid-Screen
11.13.1 Fluid-Screen Company Details
11.13.2 Fluid-Screen Business Overview
11.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction
11.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.13.5 Fluid-Screen Recent Development
11.14 FluimediX
11.14.1 FluimediX Company Details
11.14.2 FluimediX Business Overview
11.14.3 FluimediX PCR-based Enteric Disease Testing Introduction
11.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.14.5 FluimediX Recent Development
11.15 Fluxergy
11.15.1 Fluxergy Company Details
11.15.2 Fluxergy Business Overview
11.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction
11.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.15.5 Fluxergy Recent Development
11.16 Focus Diagnostics (DiaSorin Molecular)
11.16.1 Focus Diagnostics (DiaSorin Molecular) Company Details
11.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview
11.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction
11.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Development
11.17 Future Horizon Scientific
11.17.1 Future Horizon Scientific Company Details
11.17.2 Future Horizon Scientific Business Overview
11.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction
11.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.17.5 Future Horizon Scientific Recent Development
11.18 Genalyte
11.18.1 Genalyte Company Details
11.18.2 Genalyte Business Overview
11.18.3 Genalyte PCR-based Enteric Disease Testing Introduction
11.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.18.5 Genalyte Recent Development
11.18 GeneFluidics
11.25.1 GeneFluidics Company Details
11.25.2 GeneFluidics Business Overview
11.25.3 GeneFluidics PCR-based Enteric Disease Testing Introduction
11.25.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.25.5 GeneFluidics Recent Development
11.20 GenSpeed Biotech
11.20.1 GenSpeed Biotech Company Details
11.20.2 GenSpeed Biotech Business Overview
11.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction
11.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.20.5 GenSpeed Biotech Recent Development
11.21 Gulf Bio Analytical
11.21.1 Gulf Bio Analytical Company Details
11.21.2 Gulf Bio Analytical Business Overview
11.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction
11.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.21.5 Gulf Bio Analytical Recent Development
11.22 Hahn-Schickard
11.22.1 Hahn-Schickard Company Details
11.22.2 Hahn-Schickard Business Overview
11.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction
11.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.22.5 Hahn-Schickard Recent Development
11.23 Helvoet
11.23.1 Helvoet Company Details
11.23.2 Helvoet Business Overview
11.23.3 Helvoet PCR-based Enteric Disease Testing Introduction
11.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.23.5 Helvoet Recent Development
11.24 HemoCue
11.24.1 HemoCue Company Details
11.24.2 HemoCue Business Overview
11.24.3 HemoCue PCR-based Enteric Disease Testing Introduction
11.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.24.5 HemoCue Recent Development
11.25 Danaher
11.25.1 Danaher Company Details
11.25.2 Danaher Business Overview
11.25.3 Danaher PCR-based Enteric Disease Testing Introduction
11.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.25.5 Danaher Recent Development
11.26 IDEX Health&Science
11.26.1 IDEX Health&Science Company Details
11.26.2 IDEX Health&Science Business Overview
11.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction
11.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.26.5 IDEX Health&Science Recent Development
11.27 iLine Microsystems
11.27.1 iLine Microsystems Company Details
11.27.2 iLine Microsystems Business Overview
11.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction
11.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.27.5 iLine Microsystems Recent Development
11.28 Inflammatix
11.28.1 Inflammatix Company Details
11.28.2 Inflammatix Business Overview
11.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction
11.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.28.5 Inflammatix Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analyzers/Instruments
Table 3. Key Players of Kits/Panels
Table 4. Global PCR-based Enteric Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global PCR-based Enteric Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global PCR-based Enteric Disease Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global PCR-based Enteric Disease Testing Market Share by Regions (2016-2021)
Table 8. Global PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global PCR-based Enteric Disease Testing Market Share by Regions (2022-2027)
Table 10. PCR-based Enteric Disease Testing Market Trends
Table 11. PCR-based Enteric Disease Testing Market Drivers
Table 12. PCR-based Enteric Disease Testing Market Challenges
Table 13. PCR-based Enteric Disease Testing Market Restraints
Table 14. Global PCR-based Enteric Disease Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global PCR-based Enteric Disease Testing Market Share by Players (2016-2021)
Table 16. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR-based Enteric Disease Testing as of 2020)
Table 17. Ranking of Global Top PCR-based Enteric Disease Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by PCR-based Enteric Disease Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PCR-based Enteric Disease Testing Product Solution and Service
Table 21. Date of Enter into PCR-based Enteric Disease Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2016-2021)
Table 25. Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global PCR-based Enteric Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2016-2021)
Table 29. Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product
Table 64. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Vela Diagnostics Company Details
Table 67. Vela Diagnostics Business Overview
Table 68. Vela Diagnostics PCR-based Enteric Disease Testing Product
Table 69. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 70. Vela Diagnostics Recent Development
Table 71. CorisBioconcept Company Details
Table 72. CorisBioconcept Business Overview
Table 73. CorisBioconcept PCR-based Enteric Disease Testing Product
Table 74. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 75. CorisBioconcept Recent Development
Table 76. Meridian Life Science Company Details
Table 77. Meridian Life Science Business Overview
Table 78. Meridian Life Science PCR-based Enteric Disease Testing Product
Table 79. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 80. Meridian Life Science Recent Development
Table 81. Bio-Rad Laboratories Company Details
Table 82. Bio-Rad Laboratories Business Overview
Table 83. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product
Table 84. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 85. Bio-Rad Laboratories Recent Development
Table 86. Abbott (ALERE) Company Details
Table 87. Abbott (ALERE) Business Overview
Table 88. Abbott (ALERE) PCR-based Enteric Disease Testing Product
Table 89. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 90. Abbott (ALERE) Recent Development
Table 91. bioMerieux SA Company Details
Table 92. bioMerieux SA Business Overview
Table 93. bioMerieux SA PCR-based Enteric Disease Testing Product
Table 94. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 95. bioMerieux SA Recent Development
Table 96. Trinity Biotech Company Details
Table 97. Trinity Biotech Business Overview
Table 98. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 99. Trinity Biotech Recent Development
Table 100. DiaSorin Molecular Company Details
Table 101. DiaSorin Molecular Business Overview
Table 102. DiaSorin Molecular PCR-based Enteric Disease Testing Product
Table 103. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 104. DiaSorin Molecular Recent Development
Table 105. Etta Healthcare (Ovagene Oncology) Company Details
Table 106. Etta Healthcare (Ovagene Oncology) Business Overview
Table 107. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product
Table 108. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 109. Etta Healthcare (Ovagene Oncology) Recent Development
Table 110. ExcitePCR (PositiveID Corporation) Company Details
Table 111. ExcitePCR (PositiveID Corporation) Business Overview
Table 112. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product
Table 113. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 114. ExcitePCR (PositiveID Corporation) Recent Development
Table 115. Flow Alliance Company Details
Table 116. Flow Alliance Business Overview
Table 117. Flow Alliance PCR-based Enteric Disease Testing Product
Table 118. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 119. Flow Alliance Recent Development
Table 120. Fluid-Screen Company Details
Table 121. Fluid-Screen Business Overview
Table 122. Fluid-Screen PCR-based Enteric Disease Testing Product
Table 123. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 124. Fluid-Screen Recent Development
Table 125. FluimediX Company Details
Table 126. FluimediX Business Overview
Table 127. FluimediX PCR-based Enteric Disease Testing Product
Table 128. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 129. FluimediX Recent Development
Table 130. Fluxergy Company Details
Table 131. Fluxergy Business Overview
Table 132. Fluxergy PCR-based Enteric Disease Testing Product
Table 133. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 134. Fluxergy Recent Development
Table 135. Focus Diagnostics (DiaSorin Molecular) Company Details
Table 136. Focus Diagnostics (DiaSorin Molecular) Business Overview
Table 137. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product
Table 138. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 139. Focus Diagnostics (DiaSorin Molecular) Recent Development
Table 140. Future Horizon Scientific Company Details
Table 141. Future Horizon Scientific Business Overview
Table 142. Future Horizon Scientific PCR-based Enteric Disease Testing Product
Table 143. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 144. Future Horizon Scientific Recent Development
Table 145. Genalyte Company Details
Table 146. Genalyte Business Overview
Table 147. Genalyte PCR-based Enteric Disease Testing Product
Table 148. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 149. Genalyte Recent Development
Table 150. GeneFluidics Company Details
Table 151. GeneFluidics Business Overview
Table 152. GeneFluidics PCR-based Enteric Disease Testing Product
Table 153. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 154. GeneFluidics Recent Development
Table 155. GenSpeed Biotech Company Details
Table 156. GenSpeed Biotech Business Overview
Table 157. GenSpeed Biotech PCR-based Enteric Disease Testing Product
Table 158. GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 159. GenSpeed Biotech Recent Development
Table 160. Gulf Bio Analytical Company Details
Table 161. Gulf Bio Analytical Business Overview
Table 162. Gulf Bio Analytical PCR-based Enteric Disease Testing Product
Table 163. Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 164. Gulf Bio Analytical Recent Development
Table 165. Hahn-Schickard Company Details
Table 166. Hahn-Schickard Business Overview
Table 167. Hahn-Schickard PCR-based Enteric Disease Testing Product
Table 168. Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 169. Hahn-Schickard Recent Development
Table 170. Helvoet Company Details
Table 171. Helvoet Business Overview
Table 172. Helvoet PCR-based Enteric Disease Testing Product
Table 173. Helvoet Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 174. Helvoet Recent Development
Table 175. HemoCue Company Details
Table 176. HemoCue Business Overview
Table 177. HemoCue PCR-based Enteric Disease TestingProduct
Table 178. HemoCue Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 179. HemoCue Recent Development
Table 180. Danaher Company Details
Table 181. Danaher Business Overview
Table 182. Danaher PCR-based Enteric Disease Testing Product
Table 183. Danaher Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 184. Danaher Recent Development
Table 185. IDEX Health&Science Company Details
Table 186. IDEX Health&Science Business Overview
Table 187. IDEX Health&Science PCR-based Enteric Disease Testing Product
Table 188. IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 189. IDEX Health&Science Recent Development
Table 190. iLine Microsystems Company Details
Table 191. iLine Microsystems Business Overview
Table 192. iLine Microsystems PCR-based Enteric Disease Testing Product
Table 193. iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 194. iLine Microsystems Recent Development
Table 195. Inflammatix Company Details
Table 196. Inflammatix Business Overview
Table 197. Inflammatix PCR-based Enteric Disease Testing Product
Table 198. Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 199. Inflammatix Recent Development
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PCR-based Enteric Disease Testing Market Share by Type: 2020 VS 2027
Figure 2. Analyzers/Instruments Features
Figure 3. Kits/Panels Features
Figure 4. Global PCR-based Enteric Disease Testing Market Share by Application: 2020 VS 2027
Figure 5. Clostridium Difficile Case Studies
Figure 6. Campylobacteriosis Case Studies
Figure 7. Cholera Case Studies
Figure 8. E. coli Infection Case Studies
Figure 9. H. pylori Infection Case Studies
Figure 10. Salmonellosis Case Studies
Figure 11. Shigellosis Case Studies
Figure 12. Rotavirus Infection Case Studies
Figure 13. Norovirus Infection Case Studies
Figure 14. Parasitic Enteric Disease Case Studies
Figure 15. PCR-based Enteric Disease Testing Report Years Considered
Figure 16. Global PCR-based Enteric Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global PCR-based Enteric Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global PCR-based Enteric Disease Testing Market Share by Regions: 2020 VS 2027
Figure 19. Global PCR-based Enteric Disease Testing Market Share by Regions (2022-2027)
Figure 20. Global PCR-based Enteric Disease Testing Market Share by Players in 2020
Figure 21. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR-based Enteric Disease Testing as of 2020
Figure 22. The Top 10 and 5 Players Market Share by PCR-based Enteric Disease Testing Revenue in 2020
Figure 23. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2016-2021)
Figure 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2022-2027)
Figure 25. North America PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America PCR-based Enteric Disease Testing Market Share by Type (2016-2027)
Figure 27. North America PCR-based Enteric Disease Testing Market Share by Application (2016-2027)
Figure 28. North America PCR-based Enteric Disease Testing Market Share by Country (2016-2027)
Figure 29. United States PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe PCR-based Enteric Disease Testing Market Share by Type (2016-2027)
Figure 33. Europe PCR-based Enteric Disease Testing Market Share by Application (2016-2027)
Figure 34. Europe PCR-based Enteric Disease Testing Market Share by Country (2016-2027)
Figure 35. Germany PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific PCR-based Enteric Disease Testing Market Share by Type (2016-2027)
Figure 43. Asia-Pacific PCR-based Enteric Disease Testing Market Share by Application (2016-2027)
Figure 44. Asia-Pacific PCR-based Enteric Disease Testing Market Share by Region (2016-2027)
Figure 45. China PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America PCR-based Enteric Disease Testing Market Share by Type (2016-2027)
Figure 53. Latin America PCR-based Enteric Disease Testing Market Share by Application (2016-2027)
Figure 54. Latin America PCR-based Enteric Disease Testing Market Share by Country (2016-2027)
Figure 55. Mexico PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa PCR-based Enteric Disease Testing Market Share by Type (2016-2027)
Figure 59. Middle East & Africa PCR-based Enteric Disease Testing Market Share by Application (2016-2027)
Figure 60. Middle East & Africa PCR-based Enteric Disease Testing Market Share by Country (2016-2027)
Figure 61. Turkey PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE PCR-based Enteric Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 65. Vela Diagnostics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 66. CorisBioconcept Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 67. Meridian Life Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 68. Bio-Rad Laboratories Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 69. Abbott (ALERE) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 70. bioMerieux SA Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 71. Trinity Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 72. DiaSorin Molecular Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 73. Etta Healthcare (Ovagene Oncology) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 74. ExcitePCR (PositiveID Corporation) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 75. Flow Alliance Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 76. Fluid-Screen Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 77. FluimediX Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 78. Fluxergy Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 79. Focus Diagnostics (DiaSorin Molecular) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 80. Future Horizon Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 81. Genalyte Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 82. GeneFluidics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 83. GenSpeed Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 84. Gulf Bio Analytical Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 85. Hahn-Schickard Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 86. Helvoet Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 87. HemoCue Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 88. Danaher Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 89. IDEX Health&Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 90. iLine Microsystems Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 91. Inflammatix Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2016-2021)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
世界の腸疾患検査市場規模・現状・予測（2021年-2027年） Enteric diseases are gastrointestinal infections caused by microbes such as bacteria, viruses, and parasites when they enter the body through the mouth or intestinal systems. The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease …- 世界の腸疾患検査・治療市場規模・現状・予測（2021年-2027年） Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases. Ac…
- 世界のクロストリジウム・ディフィシル感染症治療市場規模・現状・予測（2021年-2027年） Clostridium difficile is one of the most common hospital acquired infections and in the last decade, there has been a notable increase in the incidence of clostridium difficile infection as well as the severity of the infection owing to recurrence and antibiotic resistance. Disproportionately higher…
- 世界の菌血症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bloodstream Infection Testing Market The global Bloodstream Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の血液感染検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blood Infection Testing Market The global Blood Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…